VARDENAFIL SANDOZ 10 mg, film-coated tablet 8 tablets
Active ingredients: Vardenafil hydrochloride trihydrate, Vardenafil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet8 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VARDENAFIL SANDOZ 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 8 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 26 Aug 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67933697CIP73010891CIP133400930108918Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VARDÉNAFILcomprimé | 10 mg · un comprimé | FT |
| CHLORHYDRATE DE VARDÉNAFIL TRIHYDRATÉcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.